Your browser doesn't support javascript.
loading
An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer.
Gogate, Anagha; Rotter, Jason S; Trogdon, Justin G; Meng, Ke; Baggett, Christopher D; Reeder-Hayes, Katherine E; Wheeler, Stephanie B.
Afiliação
  • Gogate A; Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, 27599, USA. gogate@live.unc.edu.
  • Rotter JS; Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, 27599, USA.
  • Trogdon JG; Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, 27599, USA.
  • Meng K; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Baggett CD; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Reeder-Hayes KE; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Wheeler SB; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
Breast Cancer Res Treat ; 174(2): 343-355, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30603995

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Inibidores de Proteínas Quinases / Tratamento Farmacológico Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Inibidores de Proteínas Quinases / Tratamento Farmacológico Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article